Canada markets closed

GlobeStar Therapeutics Corporation (GSTC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00050.0000 (0.00%)
At close: 03:14PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 581.46k
Enterprise Value 951.26k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)78.20k
Price/Book (mrq)N/A
Enterprise Value/Revenue 82.75k
Enterprise Value/EBITDA -0.97

Trading Information

Stock Price History

Beta (5Y Monthly) 1.59
52-Week Change 3-89.58%
S&P500 52-Week Change 326.27%
52 Week High 30.0082
52 Week Low 30.0004
50-Day Moving Average 30.0012
200-Day Moving Average 30.0016

Share Statistics

Avg Vol (3 month) 38.57M
Avg Vol (10 day) 319.04M
Shares Outstanding 51.16B
Implied Shares Outstanding 61.16B
Float 81.08B
% Held by Insiders 17.45%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:100
Last Split Date 3Jun 30, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.98M
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)375.27k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)N/A
Book Value Per Share (mrq)-0.00

Cash Flow Statement

Operating Cash Flow (ttm)-209.42k
Levered Free Cash Flow (ttm)N/A